The crystal structure is shown in the gure. Tables 1-3 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Source of material
The most important and straight forward method for the synthesis of the title compound involves the direct condensation of β-dicarbonyl compounds with amines at re ux in an aromatic solvent with azeotropic removal of water [8, 9] . To a solution of 3,4-dimethoxyacetophenone (1.80 g, 0.01 mol) in dimethylformamide-dimethylacetal (1.91 g, 0.015 mol) in dry xylene (20 mL) was re uxed for 24 h. The obtained solid was collected by lteration and recrystallized from dioxane to give the title compound.
Yield 
Experimental details
Cell re nement and data reduction were carried out by Bruker SAINT and SHELXS-97 [10, 11] . All hydrogen atoms were idealized and re ned using a riding model with the help of of the SHELX-2008 program (AFIX43 or AFIX 137 option) [10] .
Discussion
Enaminones or enamine of β-dicarbonyl compounds and their chemistry has been reviewed [1, 2] . These enaminones have demonstrated a potential as multipurpose synthetic intermediates in organic synthesis [3, 4] , in the pharmaceutical development [4] [5] [6] [7] and in heterocyclic synthesis [4] . The aim of this work was to design a novel E-1-(3,4-dimethxyphenyl)-3-(dimethylamino)prop-2-en-1-one having a biologically active 3,4-dimethoxyphenyl moiety.
The crystal structure of the title compound contains one molecule in the asymmetric unit. In the title molecule C8-C9 bond length is 1.363(3) Å and this is typical C-C double bond. In the crystal structure the molecules are stabilized by two intermolecular non-classical hydrogen bonds, of which O1 and O3 work as hydrogen bond acceptors and C10 and C11 work as hydrogen bond donors. The distance of the interactions between C10-H10C· · · O2 is 2.58(2) Å and C11-H11A· · · O3 is 2.59 Å and the angles are 168°and 122°, respectively.
